San Francisco, CA – According to filings with the U.S. Securities and Exchange Commission, Freedom Biosciences is raising $10,500,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Dina Burkitbayeva played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Freedom Biosciences
Freedom Biosciences is a leading biotechnology platform developing next-generation psychedelic therapeutics. Co-founded and led by Dr. John Krystal, Chair of the Department of Psychiatry at Yale University, and Dina Burkitbayeva, co-founder of PsyMed Ventures, Freedom Biosciences has brought together a team of pioneering professionals in the fields of science and business to focus on fulfilling the great promise of psychedelic pharmaceuticals, a novel class of antidepressants. Dr. Krystal is one of the pioneering researchers in psychiatry and alongside Dr. Robert Berman, Freedom Bio’s Head of Scientific Advisory Board, first demonstrated ketamine’s rapid antidepressant effects in the 1990s, the discovery of which directly led to FDA approval of Jannsen’s Spravato Esketamine spray. Through Dr. Krystal’s work with military veterans and those living with severe mental health and substance use disorders, Dr. Krystal has witnessed the need for novel treatment options and the life-changing benefits for those who receive them. Freedom Biosciences is creating the next generation of psychedelic pharmaceuticals by leveraging the known pharmacology of ketamine and psychedelic-based therapeutics to develop more viable and efficacious treatment alternatives for millions of people currently suffering from debilitating mental health disorders. Freedom Biosciences’ team is proud to be on the cutting edge of the psychedelics revolution.

To learn more about Freedom Biosciences, visit http://www.freedombio.co/

Contact:
Dina Burkitbayeva, Chief Executive Officer
646-627-3644
dina@freedombio.co
https://www.linkedin.com/in/dina-burkitbayeva-93950b65/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved